title: A retrospective study of 77 cats with severe hepatic lipidosis: 1975-1990.
abstract: The physical, clinicopathologic, and survival rates of 77 cats with severe spontaneous hepatic lipidosis are detailed in this report. Cats were subdivided into groups designated as idiopathic lipidosis if no other disease process was recognized, or secondary lipidosis if another disease process was diagnosed. Cats were also subdivided into groups designated as survivors or nonsurvivors on the basis of successful recuperation at 4 months after initial diagnosis. Differences between disease and survival groups were evaluated for significance. Overall, more female cats and middle-aged cats were affected. Presenting complaints of vomiting, anorexia, weakness, and weight loss were common. Physical assessment of most cats showed obvious hepatomegaly, jaundice, dehydration, and a weight loss > or = 25% of usual body weight. Neurobehavioral signs indicative of hepatic encephalopathy, other than ptyalism and depression, were rare. Clinicopathologic features are characterized by hyperbilirubinemia and increased activities of serum ALT, AST, and ALP, with only small if any increase in gamma GT activity. Clinical features distinguishing cats with hepatic lipidosis from those with other serious cholestatic disorders include absence of hyperglobulinemia and low gamma GT activity relative to ALP activity. Although coagulation tests were abnormal in 45% of cats tested (n = 44), few cats showed clinical bleeding tendencies. Most cats received prophylactic vitamin K1 therapy. Forty two cats received aggressive nutritional and supportive care and of these 55% survived. Cats with idiopathic disease were significantly younger, had significantly higher ALP activity and bilirubin concentration, and had a slightly better survival rate than cats with secondary lipidosis. Low PCV, hypokalemia, and an older age were significantly related to nonsurvival. Because of the variety of diets and food supplements used in case management, the influence of nutritional factors on survival could not be evaluated.
authors.affiliation: Department of Clinical Sciences, New York State College of Veterinary Medicine, Ithaca.
authors.forename: S A
authors.initials: SA
authors.lastname: Center
authors.forename: M A
authors.initials: MA
authors.lastname: Crawford
authors.forename: L
authors.initials: L
authors.lastname: Guida
authors.forename: H N
authors.initials: HN
authors.lastname: Erb
authors.forename: J
authors.initials: J
authors.lastname: King
mesh_terms: D000818:Animals; D002371:Cat Diseases / Q000473:pathology / Q000503:physiopathology; D002415:Cats; D005260:Female; D008064:Lipidoses / Q000473:pathology / Q000503:physiopathology / Q000662:veterinary*; D008107:Liver Diseases / Q000473:pathology / Q000503:physiopathology / Q000662:veterinary*; D008297:Male; D012189:Retrospective Studies; D016019:Survival Analysis